
Global Memantine Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Memantine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Memantine include Eisai Co, Johnson & Johnson, Novartis AG, Ono Pharmaceutical Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited and Allergan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Memantine, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Memantine, also provides the revenue of main regions and countries. Of the upcoming market potential for Memantine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Memantine revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Memantine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Memantine revenue, projected growth trends, production technology, application and end-user industry.
Memantine Segment by Company
Eisai Co
Johnson & Johnson
Novartis AG
Ono Pharmaceutical Co Ltd
H Lundbeck A/S
Daiichi Sankyo Company Limited
Allergan
Memantine Segment by Type
Memantine Powder
Memantine Capsule
Memantine Tablet
Memantine Segment by Application
Hospital Pharmacy
Retail Pharmacy
Memantine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Memantine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Memantine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Memantine revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, The global Memantine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Memantine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Memantine include Eisai Co, Johnson & Johnson, Novartis AG, Ono Pharmaceutical Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited and Allergan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Memantine, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Memantine, also provides the revenue of main regions and countries. Of the upcoming market potential for Memantine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Memantine revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Memantine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Memantine revenue, projected growth trends, production technology, application and end-user industry.
Memantine Segment by Company
Eisai Co
Johnson & Johnson
Novartis AG
Ono Pharmaceutical Co Ltd
H Lundbeck A/S
Daiichi Sankyo Company Limited
Allergan
Memantine Segment by Type
Memantine Powder
Memantine Capsule
Memantine Tablet
Memantine Segment by Application
Hospital Pharmacy
Retail Pharmacy
Memantine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Memantine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Memantine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Memantine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Memantine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Memantine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Memantine revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
195 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Memantine Market by Type
- 1.2.1 Global Memantine Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 Memantine Powder
- 1.2.3 Memantine Capsule
- 1.2.4 Memantine Tablet
- 1.3 Memantine Market by Application
- 1.3.1 Global Memantine Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Hospital Pharmacy
- 1.3.3 Retail Pharmacy
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Memantine Market Dynamics
- 2.1 Memantine Industry Trends
- 2.2 Memantine Industry Drivers
- 2.3 Memantine Industry Opportunities and Challenges
- 2.4 Memantine Industry Restraints
- 3 Global Growth Perspective
- 3.1 Global Memantine Market Perspective (2020-2031)
- 3.2 Global Memantine Growth Trends by Region
- 3.2.1 Global Memantine Market Size by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Memantine Market Size by Region (2020-2025)
- 3.2.3 Global Memantine Market Size by Region (2026-2031)
- 4 Competitive Landscape by Players
- 4.1 Global Memantine Revenue by Players
- 4.1.1 Global Memantine Revenue by Players (2020-2025)
- 4.1.2 Global Memantine Revenue Market Share by Players (2020-2025)
- 4.1.3 Global Memantine Players Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Memantine Key Players Ranking, 2023 VS 2024 VS 2025
- 4.3 Global Memantine Key Players Headquarters & Area Served
- 4.4 Global Memantine Players, Product Type & Application
- 4.5 Global Memantine Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Memantine Market CR5 and HHI
- 4.6.3 2024 Memantine Tier 1, Tier 2, and Tier 3
- 5 Memantine Market Size by Type
- 5.1 Global Memantine Revenue by Type (2020 VS 2024 VS 2031)
- 5.2 Global Memantine Revenue by Type (2020-2031)
- 5.3 Global Memantine Revenue Market Share by Type (2020-2031)
- 6 Memantine Market Size by Application
- 6.1 Global Memantine Revenue by Application (2020 VS 2024 VS 2031)
- 6.2 Global Memantine Revenue by Application (2020-2031)
- 6.3 Global Memantine Revenue Market Share by Application (2020-2031)
- 7 Company Profiles
- 7.1 Eisai Co
- 7.1.1 Eisai Co Comapny Information
- 7.1.2 Eisai Co Business Overview
- 7.1.3 Eisai Co Memantine Revenue and Gross Margin (2020-2025)
- 7.1.4 Eisai Co Memantine Product Portfolio
- 7.1.5 Eisai Co Recent Developments
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Comapny Information
- 7.2.2 Johnson & Johnson Business Overview
- 7.2.3 Johnson & Johnson Memantine Revenue and Gross Margin (2020-2025)
- 7.2.4 Johnson & Johnson Memantine Product Portfolio
- 7.2.5 Johnson & Johnson Recent Developments
- 7.3 Novartis AG
- 7.3.1 Novartis AG Comapny Information
- 7.3.2 Novartis AG Business Overview
- 7.3.3 Novartis AG Memantine Revenue and Gross Margin (2020-2025)
- 7.3.4 Novartis AG Memantine Product Portfolio
- 7.3.5 Novartis AG Recent Developments
- 7.4 Ono Pharmaceutical Co Ltd
- 7.4.1 Ono Pharmaceutical Co Ltd Comapny Information
- 7.4.2 Ono Pharmaceutical Co Ltd Business Overview
- 7.4.3 Ono Pharmaceutical Co Ltd Memantine Revenue and Gross Margin (2020-2025)
- 7.4.4 Ono Pharmaceutical Co Ltd Memantine Product Portfolio
- 7.4.5 Ono Pharmaceutical Co Ltd Recent Developments
- 7.5 H Lundbeck A/S
- 7.5.1 H Lundbeck A/S Comapny Information
- 7.5.2 H Lundbeck A/S Business Overview
- 7.5.3 H Lundbeck A/S Memantine Revenue and Gross Margin (2020-2025)
- 7.5.4 H Lundbeck A/S Memantine Product Portfolio
- 7.5.5 H Lundbeck A/S Recent Developments
- 7.6 Daiichi Sankyo Company Limited
- 7.6.1 Daiichi Sankyo Company Limited Comapny Information
- 7.6.2 Daiichi Sankyo Company Limited Business Overview
- 7.6.3 Daiichi Sankyo Company Limited Memantine Revenue and Gross Margin (2020-2025)
- 7.6.4 Daiichi Sankyo Company Limited Memantine Product Portfolio
- 7.6.5 Daiichi Sankyo Company Limited Recent Developments
- 7.7 Allergan
- 7.7.1 Allergan Comapny Information
- 7.7.2 Allergan Business Overview
- 7.7.3 Allergan Memantine Revenue and Gross Margin (2020-2025)
- 7.7.4 Allergan Memantine Product Portfolio
- 7.7.5 Allergan Recent Developments
- 8 North America
- 8.1 North America Memantine Revenue (2020-2031)
- 8.2 North America Memantine Revenue by Type (2020-2031)
- 8.2.1 North America Memantine Revenue by Type (2020-2025)
- 8.2.2 North America Memantine Revenue by Type (2026-2031)
- 8.3 North America Memantine Revenue Share by Type (2020-2031)
- 8.4 North America Memantine Revenue by Application (2020-2031)
- 8.4.1 North America Memantine Revenue by Application (2020-2025)
- 8.4.2 North America Memantine Revenue by Application (2026-2031)
- 8.5 North America Memantine Revenue Share by Application (2020-2031)
- 8.6 North America Memantine Revenue by Country
- 8.6.1 North America Memantine Revenue by Country (2020 VS 2024 VS 2031)
- 8.6.2 North America Memantine Revenue by Country (2020-2025)
- 8.6.3 North America Memantine Revenue by Country (2026-2031)
- 8.6.4 United States
- 8.6.5 Canada
- 9 Europe
- 9.1 Europe Memantine Revenue (2020-2031)
- 9.2 Europe Memantine Revenue by Type (2020-2031)
- 9.2.1 Europe Memantine Revenue by Type (2020-2025)
- 9.2.2 Europe Memantine Revenue by Type (2026-2031)
- 9.3 Europe Memantine Revenue Share by Type (2020-2031)
- 9.4 Europe Memantine Revenue by Application (2020-2031)
- 9.4.1 Europe Memantine Revenue by Application (2020-2025)
- 9.4.2 Europe Memantine Revenue by Application (2026-2031)
- 9.5 Europe Memantine Revenue Share by Application (2020-2031)
- 9.6 Europe Memantine Revenue by Country
- 9.6.1 Europe Memantine Revenue by Country (2020 VS 2024 VS 2031)
- 9.6.2 Europe Memantine Revenue by Country (2020-2025)
- 9.6.3 Europe Memantine Revenue by Country (2026-2031)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
- 9.6.9 Nordic Countries
- 10 China
- 10.1 China Memantine Revenue (2020-2031)
- 10.2 China Memantine Revenue by Type (2020-2031)
- 10.2.1 China Memantine Revenue by Type (2020-2025)
- 10.2.2 China Memantine Revenue by Type (2026-2031)
- 10.3 China Memantine Revenue Share by Type (2020-2031)
- 10.4 China Memantine Revenue by Application (2020-2031)
- 10.4.1 China Memantine Revenue by Application (2020-2025)
- 10.4.2 China Memantine Revenue by Application (2026-2031)
- 10.5 China Memantine Revenue Share by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Memantine Revenue (2020-2031)
- 11.2 Asia Memantine Revenue by Type (2020-2031)
- 11.2.1 Asia Memantine Revenue by Type (2020-2025)
- 11.2.2 Asia Memantine Revenue by Type (2026-2031)
- 11.3 Asia Memantine Revenue Share by Type (2020-2031)
- 11.4 Asia Memantine Revenue by Application (2020-2031)
- 11.4.1 Asia Memantine Revenue by Application (2020-2025)
- 11.4.2 Asia Memantine Revenue by Application (2026-2031)
- 11.5 Asia Memantine Revenue Share by Application (2020-2031)
- 11.6 Asia Memantine Revenue by Country
- 11.6.1 Asia Memantine Revenue by Country (2020 VS 2024 VS 2031)
- 11.6.2 Asia Memantine Revenue by Country (2020-2025)
- 11.6.3 Asia Memantine Revenue by Country (2026-2031)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Memantine Revenue (2020-2031)
- 12.2 SAMEA Memantine Revenue by Type (2020-2031)
- 12.2.1 SAMEA Memantine Revenue by Type (2020-2025)
- 12.2.2 SAMEA Memantine Revenue by Type (2026-2031)
- 12.3 SAMEA Memantine Revenue Share by Type (2020-2031)
- 12.4 SAMEA Memantine Revenue by Application (2020-2031)
- 12.4.1 SAMEA Memantine Revenue by Application (2020-2025)
- 12.4.2 SAMEA Memantine Revenue by Application (2026-2031)
- 12.5 SAMEA Memantine Revenue Share by Application (2020-2031)
- 12.6 SAMEA Memantine Revenue by Country
- 12.6.1 SAMEA Memantine Revenue by Country (2020 VS 2024 VS 2031)
- 12.6.2 SAMEA Memantine Revenue by Country (2020-2025)
- 12.6.3 SAMEA Memantine Revenue by Country (2026-2031)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
- 13 Concluding Insights
- 14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.